Table 4.
Adverse Eventsa | Patients (N = 29), n (%) |
---|---|
Diarrhea | 21 (72) |
Tremor | 11 (38) |
Abdominal pain | 10 (34) |
Cough | 10 (34) |
Pyrexia | 8 (28) |
Weight decreased | 7 (24) |
Nasopharyngitis | 7 (24) |
Vomiting | 6 (21) |
Convulsions | 6 (21) |
Headache | 6 (21) |
Activated partial thromboplastin time prolonged | 6 (21) |
Aspartate aminotransferase increased | 6 (21) |
aAdverse events that occurred in at least 20% of patients.